Comparison RenovoRx (RNXT) with Competitors
RenovoRx (RNXT) industry is Biotechnology.
Operating Margin
RNXT-616.00%
Industry-2055.25%
Upside+1439.25%
Free Cash Flow Yield
RNXT-29.18%
Industry-1.75%
Upside-27.43%
P/E
RNXT-2.71
Industry-20.52
Upside+1780.50%
P/S
RNXT26.04
Industry10.01
Upside+160.05%
P/B
RNXT3.37
Industry5.15
Upside-34.52%